]
October 20, 2014

Community Engagement Forum Brings Sites and Researchers Together to Improve Efforts

New tools to improve communication, monitoring, and coordination introduced
August 18, 2014

Novartis Provides Drug Candidate Compounds to TB Alliance

Exclusive worldwide license from Novartis includes a novel class of drugs that is active against drug sensitive and multi-resistant strains of tuberculosis
July 30, 2014

TB Alliance Names Elana Robertson Senior Vice President, Market Access

Robertson Will Lead Initiatives to Accelerate Adoption of New TB Drug Regimens
July 30, 2014

TB Alliance Appoints Willo Brock Senior Vice President, External Affairs

Brock Will Lead Resource Development, Advocacy, Community Engagement Efforts in Support of Promising Research Pipeline
July 8, 2014

Over 50 million children infected with tuberculosis

A new study quantifying the global TB burden among children points to a huge undiagnosed reservoir of TB.
May 13, 2014

TB Alliance Appoints Dr. Nader Fotouhi, Chief Scientific Officer

Fotouhi to guide organization's discovery-stage research and clinical trials of drug candidates
April 22, 2014

TB Alliance Grants Fosun Pharma Rights to Develop, Market Promising TB Cure in China

Partnership Supports Newly Announced STAND Trial

Pages